For: | Annunziata S, Pizzuto DA, Caldarella C, Galiandro F, Sadeghi R, Treglia G. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis. World J Gastroenterol 2015; 21(40): 11481-11488 [PMID: 26523112 DOI: 10.3748/wjg.v21.i40.11481] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11481.htm |
Number | Citing Articles |
1 |
Shraddha Patkar, Aditya Kunte, Vikram Chaudhari, Mahesh Goel. Outcomes of incidental versus non‐incidental T2 gallbladder cancer: A single‐institute experience of 425 cases. Journal of Surgical Oncology 2024; 129(4): 754 doi: 10.1002/jso.27562
|
2 |
Niharika Bisht, Nishant Lohia, Sankalp Singh, Arti Sarin, Abhishek Mahato, Dharmesh Paliwal, Indranil Sinha, Sharad Bhatnagar. Utility of 18-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography (18FDG PET-CT) in Gallbladder Cancer: Experience from a Tertiary Care Hospital. World Journal of Nuclear Medicine 2023; 22(04): 276 doi: 10.1055/s-0043-1777699
|
3 |
José Manuel Ramia, Jose Manuel Garcia Gil, Alba Manuel-Vazquez, Raquel Latorre-Fragua, Antonio Candia, Roberto de la Plaza-Llamas. False positive PET results due to xanthogranulomatous cholecystitis. Gastroenterología y Hepatología (English Edition) 2022; 45(1): 60 doi: 10.1016/j.gastre.2021.12.001
|
4 |
Chunmei Guo, Dengsai Peng, Ya Liu, Liming Chen, Zhanwen Huang. The Superiority of 68 Ga-FAPI-04 over 18F-FDG in a Case of Gallbladder Cancer. Nuclear Medicine and Molecular Imaging 2022; 56(5): 252 doi: 10.1007/s13139-022-00763-5
|
5 |
Motokazu Sato, Yusuke Kurita, Eiji Sakai, Seitaro Watanabe, Haruto Sanada, Tomoki Shimizu, Kenji Kanoshima, Yusuke Takai, Koki Meguro, Yuichi Sugimoto, Yusuke Biwata, Kunihiro Hosono, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima. Computed diffusion-weighted magnetic resonance imaging with high b-values in the diagnosis of gallbladder lesions. Abdominal Radiology 2022; 47(9): 3278 doi: 10.1007/s00261-022-03586-2
|
6 |
Aditya Kunte, Shraddha Patkar, Vikram Chaudhari, Mahesh Goel. Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers. Journal of Gastrointestinal Surgery 2023; 27(1): 78 doi: 10.1007/s11605-022-05495-7
|
7 |
Farshad Moradi, Andrei Iagaru. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. Seminars in Nuclear Medicine 2020; 50(5): 434 doi: 10.1053/j.semnuclmed.2020.04.002
|
8 |
Alireza Rezaee, Rathan M. Subramaniam, Markus Raderer, Werner Langsteger, Mohsen Beheshti. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. 2018; : 127 doi: 10.1016/B978-0-323-48567-8.00007-9
|
9 |
Shaifali Goel, Abhishek Aggarwal, Asif Iqbal, Manoj Gupta, Avinash Rao, Shivendra Singh. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. European Journal of Surgical Oncology 2020; 46(9): 1711 doi: 10.1016/j.ejso.2020.04.015
|
10 |
Aida Sabaté-Llobera, Gabriel Reynés-Llompart, Judit Mestres-Martí, Laura Gràcia-Sánchez, Laura Lladó, Teresa Serrano, Emilio Ramos, Montserrat Cortés-Romera. Imaging Gallbladder Lesions: What Can Positron Emission Tomography/Computed Tomography Add to the Conventional Imaging Approach?. Journal of Computer Assisted Tomography 2023; 47(3): 343 doi: 10.1097/RCT.0000000000001431
|
11 |
Angela Lamarca, Jorge Barriuso, Amarjot Chander, Mairéad G McNamara, Richard A Hubner, Derek ÓReilly, Prakash Manoharan, Juan W Valle. 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. Journal of Hepatology 2019; 71(1): 115 doi: 10.1016/j.jhep.2019.01.038
|
12 |
Marc-Anthony Chouillard, Elie K. Chouillard, Andrew A. Gumbs. Gallbladder Cancer. 2023; : 93 doi: 10.1007/978-981-19-6442-8_6
|
13 |
Archi Agrawal, Nilendu Purandare, Sneha Shah, Ameya Puranik, Venkatesh Rangarajan. PET/CT in Hepatobiliary and Pancreatic Malignancies. 2018; : 75 doi: 10.1007/978-3-319-60507-4_8
|
14 |
|
15 |
Deborah Pencharz, Malavika Nathan, Thomas L Wagner. Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT. The British Journal of Radiology 2018; 91(1084) doi: 10.1259/bjr.20170774
|
16 |
Pratyaksha Rana, Daneshwari Kalage, Raghuraman Soundararajan, Pankaj Gupta. Update on the Role of Imaging in the Diagnosis, Staging, and Prognostication of Gallbladder Cancer. Indian Journal of Radiology and Imaging 2024; doi: 10.1055/s-0044-1789243
|
17 |
Girish Kumar Parida, Raj Abhisek Panda, Kanhaiyalal Agrawal. Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis. Nuclear Medicine Communications 2021; 42(8): 846 doi: 10.1097/MNM.0000000000001405
|
18 |
Salvatore Annunziata, Daniele Antonio Pizzuto, Federica Galiandro. Evidence-based Positron Emission Tomography. 2020; : 59 doi: 10.1007/978-3-030-47701-1_7
|
19 |
Vikram Chaudhari, Manish Bhandare, Shailesh V. Shrikhande. Surgical Diseases of the Pancreas and Biliary Tree. 2018; : 391 doi: 10.1007/978-981-10-8755-4_15
|
20 |
K Søreide, R V Guest, E M Harrison, T J Kendall, O J Garden, S J Wigmore. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Journal of British Surgery 2019; 106(1): 32 doi: 10.1002/bjs.11035
|
21 |
L.-T. Chen, A. Vogel, C. Hsu, M.-H. Chen, W. Fang, E.A. Pangarsa, A. Sharma, M. Ikeda, J.O. Park, C.K. Tan, E. Regala, D. Tai, S. Tanasanvimon, C. Charoentum, C.E. Chee, A. Lui, J. Sow, D.-Y. Oh, M. Ueno, A. Ramaswamy, W.S. Jeo, J. Zhou, G. Curigliano, T. Yoshino, L.-Y. Bai, G. Pentheroudakis, N.-J. Chiang, A. Cervantes, J.-S. Chen, M. Ducreux. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer. ESMO Open 2024; 9(8): 103647 doi: 10.1016/j.esmoop.2024.103647
|
22 |
Motoki Nishimura, Nagara Tamaki, Shigenori Matsushima, Kei Yamada. Diseases of the Gallbladder. 2020; : 191 doi: 10.1007/978-981-15-6010-1_18
|
23 |
Shraddha Patkar, Aditi Chaturvedi, Mahesh Goel, Venkatesh Rangarajan, Ashutosh Sharma, Reena Engineer. Role of positron emission tomography‐contrast enhanced computed tomography in locally advanced gallbladder cancer. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(4): 164 doi: 10.1002/jhbp.712
|
24 |
Gopinath Gnanasegaran, Kanhaiyalal Agrawal, Simon Wan. 18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies. PET Clinics 2022; 17(3): 369 doi: 10.1016/j.cpet.2022.03.007
|
25 |
Vikram A. Chaudhari, Manish S. Bhandare, Shailesh V. Shrikhande. Incidental Gallbladder Cancer—Current Recommendations and Management Protocols. Indian Journal of Surgery 2021; 83(S4): 845 doi: 10.1007/s12262-021-02828-9
|
26 |
Can Li, Xiaohui Luan, Xiao Bi, Shengxin Chen, Yue Pan, Jingfeng Zhang, Yun Han, Xiaodan Xu, Guanyun Wang, Baixuan Xu. Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10599-7
|
27 |
Vikas Gupta, K. S. Vishnu, Thakur D. Yadav, Yashwant R. Sakaray, Santosh Irrinki, B. R. Mittal, N. Kalra, K. Vaiphei. Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening. Journal of Gastrointestinal Cancer 2019; 50(4): 901 doi: 10.1007/s12029-018-0176-2
|
28 |
Georgios D. Koimtzis, Christopher G. Chalklin, Eliot Carrington-Windo, Mark Ramsden, Leandros Stefanopoulos, Christoforos S. Kosmidis. The Role of Fine Needle Aspiration Cytology in the Diagnosis of Gallbladder Cancer: A Systematic Review. Diagnostics 2021; 11(8): 1427 doi: 10.3390/diagnostics11081427
|
29 |
Esra Arslan, Tevfik Fikret Çermik. PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas. Seminars in Nuclear Medicine 2021; 51(5): 502 doi: 10.1053/j.semnuclmed.2021.04.006
|
30 |
焕清 李. Progress in Early Diagnosis of Primary Gallbladder Cancer. Advances in Clinical Medicine 2022; 12(10): 9314 doi: 10.12677/ACM.2022.12101348
|
31 |
Margarita Kirienko, Fabrizia Gelardi, Francesco Fiz, Matteo Bauckneht, Gaia Ninatti, Cristiano Pini, Alberto Briganti, Massimo Falconi, Wim J. G. Oyen, Winette T. A. van der Graaf, Martina Sollini. Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication. European Journal of Nuclear Medicine and Molecular Imaging 2024; 52(1): 208 doi: 10.1007/s00259-024-06882-9
|
32 |
José Manuel Ramia, Jose Manuel Garcia Gil, Alba Manuel-Vazquez, Raquel Latorre-Fragua, Antonio Candia, Roberto de la Plaza-Llamas. Colecistitis xantogranulomatosa como causa de falso positivo en PET. Gastroenterología y Hepatología 2022; 45(1): 60 doi: 10.1016/j.gastrohep.2020.08.011
|
33 |
Dhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, Vivek Subbiah, Ishwaria M. Subbiah, Catherine Devine. Current update on gallbladder carcinoma. Abdominal Radiology 2021; 46(6): 2474 doi: 10.1007/s00261-020-02871-2
|
34 |
Laura Hickman, Carlo Contreras. Gallbladder Cancer. Surgical Clinics of North America 2019; 99(2): 337 doi: 10.1016/j.suc.2018.12.008
|
35 |
Hendrien Kuipers, Frederik JH Hoogwater, Gea A Holtman, Anouk van der Hoorn, Marieke T de Boer, Robbert J de Haas. Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysis. Acta Radiologica 2021; 62(8): 987 doi: 10.1177/0284185120950115
|